Moreover, miR-27a has been reported to increase osteogenesis [55] and decrease adipogenesis via targeting of myocyte enhancer factor 2C (Mef2c) [56], and miR-27a was downregulated in osteoporosis patients [57]. This evidence concerns the gene MEF2C and osteoporosis.